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Abstract 
6p rearrangements in myeloid malignancies are 
characterized by heterogeneous breakpoints and 
chromosome abnormalities that involve various 
partner chromosomes. Balanced chromosome  
translocations involving 6p21 are infrequent, among 
them the t(6;17)(p21;p13 has been observed only in 
sporadic cases. 
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Figure 1. Partial karyotypes showing t(6;21)(p21;p13). 
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Figure 2.  Hybridization with SureFISH PAFAH1B1 probe hybridizing to 17p13.3 showing  translocation of 17p sequences to 
der(6) chromosome (green signal) (A). FISH with SureFISH RUNX2 probe located on 6p21.1 revealed  signals on normal and 
der(6) chromosomes (B). Simultaneous hybridization with SureFISH PAFAH1B1 and RUNX2 probes showed normal signal 
pattern on metaphase without t(6;17)(p21;p13) (C) and cohybridization of PAFAH1B1 and RUNX2 probes on der(6) chromosome 
(red-green signal) (D). 
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Clinics and pathology 
Disease 
Myeloid malignancies 
Phenotype/cell stem origin 
1 acute myeloblastic leukemia with maturation 
(AML-M2) (La Starza et al., 2006), 1 
myelodysplastic syndrome (MDS) that terminated in 
acute myeloid leukemia without maturation (AML-
M1) and 1 AML with t(3;3)(q21;q26.2) (present 
cases, see the Case Reports t(6;17)(p21;p13) 
associated with t(3;3)(q21;q26.2) in AML and 
t(6;17)(p21;p13) and acquisition of the Philadelphia 
chromosome translocation with p190 BCR-ABL1 
transcript during the course of myelodysplastic 
syndrome).  
Note: an identical anomaly was also detected in 2 
patients with aneurysmal bone cysts 
(Winnepenninckx et al., 2001; Althof et al., 2004). 
Epidemiology 
Only sporadic cases: 2 males aged 47 and 86 years  
and a 25-years old female. 
Genetics 
Note 
Putative candidate genes at 6p21 include CCND3 at 
6p21.1 and MHC complex, NOTCH4, BAK1, 
FANCE, ETV7, HMGA1, FKBP5 at 6p21.3 (La 
Starza et al., 2006). 
Cytogenetics 
Cytogenetics morphological 
Found in association with +11 in AML-M2 and with 
+8 during MDS phase in the present patient in whom 
progression from MDS to AML was accompanied 
by an appearance of a new clone, t(9;22)(q34;q11) 
with the minor p190 BCR/ ABL1 transcript as an 
additional anomaly to initial chromosome 
abnormalities.  
Found in a sideline in AML with t(3;3)(q21;q26.2) 
and monosomy 7. 
 
Result of the chromosomal 
anomaly 
Fusion protein 
Oncogenesis 
The chromosomal translocation t(6;17)(p21;p13) is 
a rare anomaly that has been described in myeloid 
malignancies. Found in association with numerical 
chromosome anomalies such as +11, +8 and -7, 
therefore t(6;17)(p21;p13) is probably a secondary 
anomaly arising from a genetically unstable 
progenitor cell, acquiring subsequent genetic 
events.As these trisomies and monosomy 7 are 
known numerical aberrations in MDS and AML, it 
is likely that the occurrence of numerical anomalies 
may be a major pathogenetic event in these patients. 
Alternatively, it is possible that t(6;17)(p21;p13) was 
a primary anomaly associated with the early stage of 
disease that was replaced by a clone containing 
numerical anomalies during the course of a 
hematologic malignancy. The acquisition of 
t(9;22)(q34;q11) to initial anomalies in 1 patient  
indicates, that the Ph is certainly a secondary event 
that arose through multiple cytogenetic evolutions, 
the final event of which was the development of 
t(9;22)(q34;q11). 
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